Mar 01, 2017 8:30am EST Adaptimmune Cuts Ribbon on U.S. Headquarters at the Navy Yard in Philadelphia
Jan 09, 2017 8:01am EST Adaptimmune confirms GSK Nomination of Second Adaptimmune Target under Strategic Multi-Target Collaboration
Jan 09, 2017 8:01am EST Adaptimmune Announces New Senior Vice President of Global Bio-Process and Development
Jan 09, 2017 8:00am EST Adaptimmune Announces FDA Acceptance of IND Application for Affinity Enhanced T-Cell Therapy Targeting MAGE-A4 in Multiple Solid Tumors
Dec 19, 2016 7:30am EST Adaptimmune and Bellicum Pharmaceuticals Enter a Strategic Collaboration to Evaluate Next-Generation T-Cell Therapies
Nov 11, 2016 11:18am EST Adaptimmune Announces Update on Clinical Data from NY-ESO SPEAR™ T-cell Synovial Sarcoma Study at the 2016 Annual Meeting of the Connective Tissue Oncology Society (CTOS)
Nov 11, 2016 8:30am EST Adaptimmune Presents Preclinical Data from a New, Wholly-owned SPEAR™ T-cell and a Second Generation SPEAR T-cell at the 31st Annual Meeting of the Society for Immunotherapy for Cancer (SITC)
